Skip to main content
Clinical Trials/NCT01731743
NCT01731743
Completed
Not Applicable

Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses

Carl Zeiss Meditec AG1 site in 1 country107 target enrollmentJanuary 2012
ConditionsCataract

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Carl Zeiss Meditec AG
Enrollment
107
Locations
1
Primary Endpoint
Intermediate visual acuity
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.

Detailed Description

After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction. A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
July 2013
Last Updated
8 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Man or woman, over 50 years of age
  • Bilateral implantation of a trifocal intraocular lens
  • Capsular bag implantation

Exclusion Criteria

  • Existing ocular pathology
  • Surgical complications
  • Corneal astigmatism ≥ 1.0D

Outcomes

Primary Outcomes

Intermediate visual acuity

Time Frame: up to 3 months postoperatively

Monocular and binocular uncorrected and best distance corrected

Secondary Outcomes

  • near and far visual acuity(1 and 3 month postoperatively)

Study Sites (1)

Loading locations...

Similar Trials